Wed, March 1, 2023
Tue, February 28, 2023
Mon, February 27, 2023

Douglas Tsao Reiterated (TBPH) at Strong Buy and Held Target at $19 on, Feb 28th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-19-on-feb-28th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Douglas Tsao of HC Wainwright & Co., Reiterated "Theravance Biopharma, Inc." (TBPH) at Strong Buy and Held Target at $19 on, Feb 28th, 2023.

Douglas has made no other calls on TBPH in the last 4 months.



There is 1 other peer that has a rating on TBPH. Out of the 1 peers that are also analyzing TBPH, 0 agree with Douglas's Rating of Hold.



This is the rating of the analyst that currently disagrees with Douglas


  • David Risinger of "SVB Leerink" Maintained at Buy with Increased Target to $14 on, Thursday, November 17th, 2022

Publication Contributing Sources